These 4 innovations were in the works prior to COVID-19, but the pandemic presented the right conditions for them to connect.
MM&M examines five organizations going all in with game-changing ideas that have the chance to revolutionize the industry, but they don’t come without risk.
Saskia Steinacker is global head of digital transformation at Bayer.
Marc Speichert is global chief digital officer, consumer healthcare at GlaxoSmithKline.
Bertrand Bodson is chief digital officer at Novartis.
Heather Bell is SVP, global head of digital and analytics at Sanofi.
Marc Leibowitz is global head of health technology and digital health at Johnson & Johnson.
Armed with a great depth of expertise from a diverse array of industries, including beauty, retail, apparel, big tech, and startups, chief digital officers are helping pharma transform.
Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.
How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.